Dr. Archna Bajaj, MD
Claim this profileNovartis Investigative Site
Studies Cardiovascular Disease
Studies Atherosclerosis
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Archna Bajaj, MD is currently running
Plozasiran
for High Triglycerides
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo, and be evaluated for efficacy and safety. After Month 12, eligible participants will be offered an opportunity to continue in an optional open-label extension under a separate protocol.
Recruiting1 award Phase 31 criteria
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting1 award Phase 3
More about Archna Bajaj, MD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Archna Bajaj, MD has experience with
- Pelacarsen (TQJ230)
- Lepodisiran
- Obicetrapib
- Plozasiran Injection
Breakdown of trials Archna Bajaj, MD has run
Cardiovascular Disease
Atherosclerosis
Elevated Lipoprotein
Metabolism of Lipids
High Triglycerides
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Archna Bajaj, MD specialize in?
Archna Bajaj, MD focuses on Cardiovascular Disease and Atherosclerosis. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Archna Bajaj, MD currently recruiting for clinical trials?
Yes, Archna Bajaj, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Archna Bajaj, MD has studied deeply?
Yes, Archna Bajaj, MD has studied treatments such as Pelacarsen (TQJ230), Lepodisiran, Obicetrapib.
What is the best way to schedule an appointment with Archna Bajaj, MD?
Apply for one of the trials that Archna Bajaj, MD is conducting.
What is the office address of Archna Bajaj, MD?
The office of Archna Bajaj, MD is located at: Novartis Investigative Site, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Novartis Investigative Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.